COVID-19 Updates
From the Journals
Add this to the list of long COVID symptoms: Stigma
Most people with long COVID find they’re facing stigma due to their condition, a new study finds.
Feature
New Omicron subvariant is ‘crazy infectious,’ COVID expert warns
‘All the things that have protected you for the past couple of years, I don’t think are going to protect you against this new crop of variants,’...
From the Journals
New study offers details on post-COVID pediatric illness
This pediatric illness occurs 2-6 weeks after being infected with COVID-19.
Latest News
What’s next for COVID? Here’s what to know
“We are in the midst of [a surge] now, It’s not nearly like what we’ve had in Omicron or other waves; it’s not as severe. But it’s being...
Feature
Study of beliefs about what causes cancer sparks debate
The authors set out to evaluate “the patterns of beliefs about cancer among people who believed in conspiracies, rejected the COVID-19 vaccine, or...
From the Journals
Endocarditis tied to drug use on the rise, spiked during COVID
The steepest rise of infective endocarditis in people with cocaine/opioid use disorder occurred during the pandemic, suggesting COVID itself may...
Feature
COVID booster shot poll: People ‘don’t think they need one’
A new poll shows why so few people are willing to get the latest COVID booster.
Feature
Rise of ‘alarming’ subvariants of COVID ‘worrisome’ for winter
This means people have no or “markedly reduced” protection against infection from these four strains.
Feature
U.S. sees most flu hospitalizations in a decade
But the number of deaths and outpatient visits for flu or flu-like illnesses was down slightly from the week before.
Feature
As COVID treatments dwindle, are new ones waiting in the wings?
Bebtelovimab couldn’t neutralize the Omicron subvariants BQ.1 and BQ.1.1.
Commentary
How a cheap liver drug may be the key to preventing COVID
The authors of a paper appearing in Nature give us multiple, complementary lines of evidence.